Experimental Alzheimer's drug slows cognitive decline in trial, firms say - 1breakingnews.com
- 2 years ago
Makers of the drug have already applied to the Food and Drug Administration for accelerated approval for lecanemab, based on earlier-stage data.
VIEW MORE : https://bit.ly/1breakingnews
VIEW MORE : https://bit.ly/1breakingnews